| Expression of the v-erbA oncogene in chicken embryo fibroblasts stimulates their proliferation in vitro and enhances tumor growth in vivo. | None |
| Biological effects of the v-erbA oncogene in transformation of avian erythroid cells. | None |
| Nucleotide sequence of the chicken proto-oncogene c-erbA corresponding to domain 1 of v-erbA. | None |
| The chicken c-erbA proto-oncogene is preferentially expressed in erythrocytic cells during late stages of differentiation. | None |
| Germ-line chromosomal localization of human C-Erb-A oncogene. | None |
| Sequencing the erbA gene of avian erythroblastosis virus reveals a new type of oncogene. | None |
| Induction of platelet-derived growth factor B/c-sis by the v-erbA oncogene in glial cells. | None |
| c-erbA alpha/T3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis or differentiation and are antagonized by the v-erbA oncogene. | None |
| The v-erbA oncoprotein of the AEV transforming retrovirus binds to the promoter region of the erythroid-specific band 3 gene. | None |
| The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms. | None |
| Overexpression of c-erbA proto-oncogene enhances myogenic differentiation. | None |
| v-erbA oncogene induces invasiveness and anchorage-independent growth in cultured glial cells by mechanisms involving platelet-derived growth factor. | None |
| Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo. | None |